Shehnaaz Suliman

Director, 10x Genomics, Inc.; Director, Ultragenyx Pharmaceutical Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.9M

Companies

Latest trade

Sep 22, 2026

Companies

10x Genomics, Inc.Director −$0.8M Ultragenyx Pharmaceutical Inc.Director −$0.1M

Trades

TXG Sold 5,723 shares at $81.19 · planned $0.5M Sep 22

TXG Sold 2,207 shares at $63.65 · planned $0.1M Aug 24

TXG Sold 5,723 shares at $32.63 · planned $0.2M Jun 16

RARE Sold 5,740 shares at $25.12 · planned $0.1M May 18

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.